We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Serological Test Differentiates Zika from Dengue Infections

By LabMedica International staff writers
Posted on 26 Jan 2017
Print article
Image: The enzyme-linked immunosorbent assay (ELISA) for ZIKA virus (Photo courtesy of EUROIMMUN).
Image: The enzyme-linked immunosorbent assay (ELISA) for ZIKA virus (Photo courtesy of EUROIMMUN).
Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus currently causing large epidemics in South and Central America as well as in the Caribbean, presenting a global public health emergency.

Zika is increasingly posing a risk in other parts of the world and it is difficult to differentiate clinically from infections with dengue and chikungunya viruses, which are endemic in the same geographical regions. In laboratory testing, serology is an important supplement to direct detection and provides a much longer diagnostic window.

European scientists led by those at the Institute for Experimental Immunology analyzed serum samples from 27 patients who had tested positive for ZIKV RNA by reverse transcription polymerase chain reaction (RT-PCR); Samples from a further 85 patients had been pre-characterized by EUROIMMUN’s anti-ZIKV indirect immunofluorescence assay based on whole virus antigen, showing reactivity for anti-ZIKV immunoglobulin M (IgM) and/or IgG; 26 travelers returning from endemic area; and 59 residents in ZIKV-endemic areas. Anti-Zika Virus IgM and IgG enzyme-linked immunosorbent assay ELISA (EUROIMMUN) were tested.

In 17 RT-PCR confirmed Zika specimens collected at least six days after symptom onset, the ELISA sensitivity amounted to 59%, for IgM, 88% for IgG and 100% for IgM/IgG. In the suspected Zika cases, the combined sensitivity was 90%. In an additional investigation using samples from 31 patients with RT-PCR confirmed Zika virus infections (follow-up samples taken 7-10 days after positive RT-PCR result); the ELISA demonstrated a sensitivity of 100% for IgM/IgG. The specificity of the ELISA with respect to the blood donors was 99.8%. Cross reactivity with high-level anti-dengue virus antibodies was not detectable. Among 252 patients with potentially cross-reactive antibodies, overall anti-Zika positive rates were 0.8% for IgM and 0.4% for IgG.

The authors concluded that the ELISA provided exceptionally high specificity and avoids the cross reactivity typically associated with tests based on whole virus antigens or viral glycoproteins. The anti-Zika virus ELISA is suitable for acute diagnostics as well as for monitoring purposes, e.g., in prenatal diagnostics, screening of donated blood and epidemiological studies. With its high-throughput format and automatability, the ELISA can be employed in routine laboratories in endemic settings. The study was published on December 16, 2016, in the journal Eurosurveillance.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.